R.H. Bluestein & Co’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.45M | Sell |
|
|||||
|
2022
Q2 | $2.31M | Sell |
|
|||||
|
2022
Q1 | $4.05M | Sell |
|
|||||
|
2021
Q4 | $34.9M | Buy |
|
|||||
|
2021
Q3 | $35.4M | Buy |
|
|||||
|
2021
Q2 | $26.1M | Buy |
|
|||||
|
2021
Q1 | $20.6M | Buy |
|
|||||
|
2020
Q4 | $17.1M | Buy |
|
|||||
|
2020
Q3 | $16.8M | Sell |
|
|||||
|
2020
Q2 | $16.6M | Buy |
|
|||||
|
2020
Q1 | $8.84M | Buy |
|
|||||
|
2019
Q4 | $1.8M | Sell |
|
|||||
|
2019
Q3 | $1.32M | Sell |
|
|||||
|
2019
Q2 | $1.36M | Hold |
|
|||||
|
2019
Q1 | $1.08M | Sell |
|
|||||
|
2018
Q4 | $1.09M | Sell |
|
|||||
|
2018
Q3 | $1.35M | Sell |
|
|||||
|
2018
Q2 | $899K | Buy |
|
|||||
|
2018
Q1 | $636K | Sell |
|
|||||
|
2017
Q4 | $501K | Hold |
|
|||||
|
2017
Q3 | $427K | Sell |
|
|||||
|
2017
Q2 | $15.6M | Buy |
|
|||||
|
2017
Q1 | $15.7M | Buy |
|
|||||
|
2016
Q4 | $6.03M | Buy |
|
|||||
|
2016
Q3 | $438K | Buy |
|
|||||
|
2016
Q2 | $238K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.06M | Sell |
|
|||||
|
2015
Q3 | $1.25M | Buy |
|
|||||
|
2015
Q2 | $1.08M | Hold |
|
|||||
|
2015
Q1 | $842K | Hold |
|
|||||
|
2014
Q4 | $743K | Hold |
|
|||||
|
2014
Q3 | $540K | Hold |
|
|||||
|
2014
Q2 | $535K | Hold |
|
|||||
|
2014
Q1 | $558K | Buy |
|
|||||
|
2013
Q4 | $336K | Hold |
|
|||||
|
2013
Q3 | $268K | Hold |
|
|||||
|
2013
Q2 | $213K | Buy |
|